Business

January 21, 2014 11:52 AM

Durham's Argos Therapeutics looking to raise up to $60 million with IPO

Argos Therapeutics is hoping that Wall Street will value its business in the neighborhood of $250 million. The Durham drug-development company provided more details Tuesday in its latest filing with the Securities and Exchange Commission.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs